In one paragraphArticle in Biomedicines, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
15 authors.
Karin Albrecht-SchgörInstitute for Cell Genetics, Medical University of Innsbruck, 6020 Innsbruck, Austria.ORCID 0009-0007-0336-7130 Victoria E StefanResearch Program for Receptor Biochemistry and Tumor Metabolism, Department of Pediatrics, University Hospital of the Paracelsus Medical University Salzburg, 5020 Salzburg, Austria.ORCID 0009-0001-6388-3766 Martina SteinlechnerInstitute for Cell Genetics, Medical University of Innsbruck, 6020 Innsbruck, Austria.ORCID 0009-0008-8925-8484 Kerstin SiegmundInstitute for Cell Genetics, Medical University of Innsbruck, 6020 Innsbruck, Austria.ORCID 0000-0002-3654-1170 Sebastian PeerInternal Medicine V (Hematology and Oncology), Medical University of Innsbruck, 6020 Innsbruck, Austria.ORCID 0000-0002-4372-5365 Maja ÜbereggerInstitute for Neurobiochemistry, Medical University of Innsbruck, 6020 Innsbruck, Austria.
Stephanie Zur NeddenInstitute for Neurobiochemistry, Medical University of Innsbruck, 6020 Innsbruck, Austria.ORCID 0000-0002-2111-0757 Gabriele Baier-BitterlichInstitute for Neurobiochemistry, Medical University of Innsbruck, 6020 Innsbruck, Austria.ORCID 0000-0002-7009-8168 Peter LacknerVienna Healthcare Group, Department of Neurology, Klinik Floridsdorf, 1010 Vienna, Austria.ORCID 0000-0002-3481-7911 Nikolaus ThuilleInstitute for Cell Genetics, Medical University of Innsbruck, 6020 Innsbruck, Austria.ORCID 0000-0002-2253-3946 Victoria KlepschInstitute for Cell Genetics, Medical University of Innsbruck, 6020 Innsbruck, Austria.ORCID 0000-0003-4146-4664 Gottfried BaierInstitute for Cell Genetics, Medical University of Innsbruck, 6020 Innsbruck, Austria.ORCID 0000-0002-2085-8325 Funding
European Research Council ADG 786462European Research Council PoC 101189004FWF Austrian Science Fund DOI: 10.55776/P31383FWF Austrian Science Fund DOI: 10.55776/P34368FWF Austrian Science Fund DOI: 10.55776/PAT1317523FWF Austrian Science Fund DOI 10.55776/PAT4090924FWF Austrian Science Fund DOI: 10.55776/PAT9292223FWF Austrian Science Fund DOI: 10.55776/T1292FWF Austrian Science Fund DOI: 10.55776/TAI80
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
CD8+ T cellscerebral malaria (CM)drug repurposingexperimental cerebral malaria (ECM)host-targeted candidate therapyimmune-mediated brain injuryneurovascular damageprotein kinase C-θ (PKCθ)
Identifiers
PMID41301677
PMCPMC12649984
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390